| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/04/1996 | CA2208319A1 Assay, receptor proteins and ligands |
| 07/04/1996 | CA2208233A1 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | CA2208072A1 Recombinant antigen for diagnosing rheumatoid arthritis |
| 07/04/1996 | CA2205091A1 Chemical compounds |
| 07/03/1996 | EP0719864A2 Recombinant live avian vaccin, using an avian herpes virus as vector |
| 07/03/1996 | EP0719863A1 Hepatitis B surface antigen formed by recombinant DNA techniques, vaccines, diagnostics, cell lines and methods of forming same |
| 07/03/1996 | EP0719859A1 Anti-alpha V-integrin monoclonal antibody |
| 07/03/1996 | EP0719560A1 Antibordetella acellular vaccine |
| 07/03/1996 | EP0719340A1 Cloned glutamic acid decarboxylase |
| 07/03/1996 | EP0719336A1 Modified plant viruses as vectors of heterologous peptides |
| 07/03/1996 | EP0719333A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 07/03/1996 | EP0719331A1 Eotaxin = eosinophil chemotactic cytokine |
| 07/03/1996 | EP0719285A1 Il8 inhibitors |
| 07/03/1996 | EP0719155A1 $i(CAMPYLOBACTER JEJUNI) ANTIGENS, AND METHODS FOR THEIR PRODUCTION AND USE |
| 07/03/1996 | EP0719150A1 Cellular vaccine and methods of use for the treatment of solid tumor malignancies |
| 07/03/1996 | EP0673653A4 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it. |
| 07/03/1996 | EP0669836B1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 07/03/1996 | EP0515433B1 Recombinant poxvirus internal cores |
| 07/03/1996 | EP0417160B1 Method for hla dp typing |
| 07/03/1996 | EP0249613B1 Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4) |
| 07/03/1996 | CN1125982A Methods of typing hepatitis C virus and reagents for use therein |
| 07/03/1996 | CN1125619A Preparation method of bacteriophagic leech and vibrio ecological preparation |
| 07/02/1996 | US5532347 DNA encoding α melanocyte stimulating hormone receptor |
| 07/02/1996 | US5532159 Antitumor agents; hybridomas |
| 07/02/1996 | US5532154 Mutated alpha virus |
| 07/02/1996 | US5532152 Platelet-activating factor acetylhydrolase |
| 07/02/1996 | US5532134 Mycoplasma diagnostic assay |
| 07/02/1996 | US5532133 Plasmodium vivax blood stage antigens, PvESP-1, antibodies, and diagnostic assays |
| 07/02/1996 | US5532127 Assay for 1-CAM related protein expression |
| 07/02/1996 | US5532123 Receptor-type phosphotyrosine phosphatase-γ |
| 07/02/1996 | US5531990 Method of raising an immune response with an anti-idiotypic antibody having correspondence with human hepatitis B surface antigen |
| 07/02/1996 | US5531989 Immunoglobulin and fiber-containing composition for human gastrointestinal health |
| 07/02/1996 | US5531988 Immunology using immunoglobulins |
| 07/02/1996 | US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates |
| 07/01/1996 | CA2166371A1 Avian herpesvirus-based live recombinant avian vaccine, in particular against gumboro disease |
| 06/27/1996 | WO1996019584A1 Chimeric antibodies comprising antigen binding sites and b and t cell epitopes |
| 06/27/1996 | WO1996019580A2 Telomerase protein component |
| 06/27/1996 | WO1996019579A1 Nuclear protein serine/threonine kinases |
| 06/27/1996 | WO1996019578A2 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN ahpCF OPERON |
| 06/27/1996 | WO1996019498A2 T cell stimulating protein of pestivirus |
| 06/27/1996 | WO1996019496A1 Variants of human papilloma virus antigens |
| 06/27/1996 | WO1996019495A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 06/27/1996 | WO1996019494A1 Peptides having immunomodulatory activity |
| 06/27/1996 | WO1996019237A1 Enhanced immunogenic vaccine |
| 06/27/1996 | WO1996019236A1 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES |
| 06/27/1996 | WO1996015237A3 Delivery system |
| 06/27/1996 | WO1996012190A3 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 06/27/1996 | CA2419289A1 Variants of human papilloma virus antigens |
| 06/27/1996 | CA2210378A1 Methods and compositions for detecting and treating mycobacterial infections using an ahpcf operon |
| 06/27/1996 | CA2208431A1 Enhanced immunogenic vaccine |
| 06/27/1996 | CA2206778A1 Peptides having immunomodulatory activity |
| 06/26/1996 | EP0718627A1 A process for preparing diagnostic reagent for syphilis |
| 06/26/1996 | EP0718309A1 Antigens and antibodies for the detection of collagen I |
| 06/26/1996 | EP0717777A1 Salmonella vaccines |
| 06/26/1996 | EP0717774A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 06/26/1996 | EP0717752A1 Therapeutic compounds |
| 06/26/1996 | EP0717636A1 Malaria recombinant poxvirus vaccine |
| 06/26/1996 | EP0717633A1 Growth differentiation factor-7 |
| 06/26/1996 | EP0717629A1 Novel eimeria antibodies and antigens and methods of using the same |
| 06/26/1996 | EP0474642B1 Chelants |
| 06/26/1996 | CN1125466A Processes for producing an enzyme |
| 06/26/1996 | CN1125399A Immunogenic cancer proteins and peptides and method of use |
| 06/26/1996 | CN1125394A Novel therapeutic drug delivery systems |
| 06/25/1996 | US5530109 DNA encoding glial mitogenic factors |
| 06/25/1996 | US5530103 Method for the purification of PC protein from Borrelia burgdorferi |
| 06/25/1996 | US5530102 Methods and compositions for the direct concentrated delivery of passive immunity |
| 06/25/1996 | US5530101 Humanized immunoglobulins |
| 06/25/1996 | US5530096 Diagnosis and therapy of tumors, autoimmune diseases |
| 06/25/1996 | US5529934 Method for measuring blood procoagulant activity of human leukocyte antigens |
| 06/25/1996 | US5529922 Anti-idiotypic monoclonal antibody that induces an immune response against the ganglioside GD3 and hybridoma producing said antibody |
| 06/25/1996 | US5529903 Extraction and cultivation of transformed cells and production of antibodies directed against them |
| 06/25/1996 | US5529898 Methods of detecting disorders of the central nervous system by detecting autoantibodies which specifically bind ionotropic glutamate receptors |
| 06/25/1996 | US5529780 Isolated nucleic acid coding for canine herpes virus glycoproteins |
| 06/25/1996 | US5529777 Hydrogel microencapsulated vaccines |
| 06/25/1996 | US5529776 Anti-HIV-1 neutralizing antibodies |
| 06/20/1996 | WO1996018725A1 Human tissue inhibitor of metalloproteinase-4 |
| 06/20/1996 | WO1996018650A1 Novel receptor |
| 06/20/1996 | WO1996018414A1 Acellular anti-bordetella vaccine |
| 06/20/1996 | WO1996018413A1 Carcinoma treatment |
| 06/20/1996 | WO1996018412A1 Chimeric cytokines and uses thereof |
| 06/20/1996 | WO1996018409A1 In vivo activation of tumor-specific cytotoxic t cells |
| 06/20/1996 | WO1996018390A1 Delivery of nucleic acid molecules to mucosal tissue |
| 06/20/1996 | WO1996012809A3 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 06/20/1996 | CA2207921A1 Novel receptor |
| 06/20/1996 | CA2207736A1 In vivo activation of tumor-specific cytotoxic t cells |
| 06/20/1996 | CA2205572A1 Chimeric cytokines and uses thereof |
| 06/19/1996 | EP0717109A1 Synthetic DNA derived recombinant HIV-2 antigens |
| 06/19/1996 | EP0717108A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins |
| 06/19/1996 | EP0717106A1 Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins |
| 06/19/1996 | EP0716701A1 Cloning of a member of the serine-threonine-kinase family |
| 06/19/1996 | EP0716697A1 DIFFERENTIALLY EXPRESSED $i(LEISHMANIA) GENES AND PROTEINS |
| 06/19/1996 | EP0716696A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
| 06/19/1996 | EP0716693A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 06/19/1996 | EP0716662A1 Dna encoding prostaglandin receptor ep2 |
| 06/19/1996 | EP0716613A1 TREATMENT OF $i(H. PYLORI) ASSOCIATED GASTRODUODENAL DISEASE |
| 06/19/1996 | EP0716612A1 Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
| 06/19/1996 | EP0621899B1 Expression signal-peptide-free staphylokinases |
| 06/19/1996 | EP0524173B1 Solubilization and purification of the gastrin releasing peptide receptor |
| 06/19/1996 | EP0506923B1 A collagen binding protein as well as its preparation |
| 06/19/1996 | EP0418310B1 Gene for encoding a human malaria vaccine antigen |